Image
Photo: Johan Wingborg
Neurochemical pathophysiology and diagnostics
Research group
Short description
The research group's main goal is to use neurochemical and molecular biology methodology to identify and study the pathophysiology of neurodegenerative diseases.
More news
- [Sept 21, 2021] Alzheimer’s disease increasingly clarified (External link)
- [Jan 13, 2021] New studies support blood test for early detection of Alzheimer’… (External link)
- [Nov 30, 2020] New tests identify early changes in Alzheimer’s disease before s… (External link)
- [May 12, 2020] Henrik Zetterberg has developed a simple blood test for Alzheime… (External link)
- [Dec 11, 2019] Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator … (External link)
- [Aug 31, 2017] New possibility of studying how Alzheimer's disease affects the … (External link)
Our main goals
The research group's main goal is to use neurochemical and molecular biology methodology to identify and study the pathophysiology of neurodegenerative diseases.
An important goal is to identify protein changes which are connected to the pathophysiology, so-called biochemical markers. The hypothesis is that biochemical markers will be valuable for diagnostic, identification of pharmaceutical effects as for studies of pathogenesis directly in our patients.
